Correlation Between NYSE Composite and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Kymera Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Kymera Therapeutics.
Diversification Opportunities for NYSE Composite and Kymera Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NYSE and Kymera is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Kymera Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.15 times more return on investment than Kymera Therapeutics. However, NYSE Composite is 6.77 times less risky than Kymera Therapeutics. It trades about 0.42 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 1,909,542 in NYSE Composite on November 2, 2024 and sell it today you would earn a total of 107,080 from holding NYSE Composite or generate 5.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Kymera Therapeutics
Performance |
Timeline |
NYSE Composite and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Kymera Therapeutics
Pair trading matchups for Kymera Therapeutics
Pair Trading with NYSE Composite and Kymera Therapeutics
The main advantage of trading using opposite NYSE Composite and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.NYSE Composite vs. Western Copper and | NYSE Composite vs. Chemours Co | NYSE Composite vs. IPG Photonics | NYSE Composite vs. Morgan Advanced Materials |
Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |